Citigroup’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-24,725
| Closed | -$2.41M | – | 6040 |
|
|
2015
Q1 | $2.41M | Buy |
24,725
+11,246
| +83% | +$1.1M | ﹤0.01% | 1241 |
|
|
2014
Q4 | $1.25M | Buy |
13,479
+10,906
| +424% | +$1.01M | ﹤0.01% | 1609 |
|
|
2014
Q3 | $177K | Buy |
2,573
+377
| +17% | +$25.9K | ﹤0.01% | 2738 |
|
|
2014
Q2 | $230K | Sell |
2,196
-4,760
| -68% | -$499K | ﹤0.01% | 2488 |
|
|
2014
Q1 | $577K | Sell |
6,956
-1,210
| -15% | -$100K | ﹤0.01% | 1972 |
|
|
2013
Q4 | $529K | Buy |
8,166
+2,773
| +51% | +$180K | ﹤0.01% | 2317 |
|
|
2013
Q3 | $341K | Buy |
5,393
+4,838
| +872% | +$306K | ﹤0.01% | 2237 |
|
|
2013
Q2 | $24K | Buy |
+555
| New | +$24K | ﹤0.01% | 4126 |
|